Welcome !
- Experts in Translational Medicine and Integrative Cancer Care -

CPT - Cytoplasmic Peptide Therapy

For nearly a century, countless doctors and medical researchers have pursued the now substantiated link between disease and morphological and molecular cell changes in patients. As early as 1931 in Switzerland, Dr. Paul Niehan pioneered cell and organ-lysate therapies, providing diseased organ with elements taken from identical healthy organs. In the last 50 years, Professor Karl Theurer of Germany furthered the work of Dr. Niehans, ultimately leading to the effective use of biological macromolecules.

More recently, advances in modern medicine and cell research have given birth to Cytoplasmatic Therapy. Distinct in nature from other organ-extract and cell-therapy techniques, Cytoplasmatic Therapy embraces a holistic approach to safely and effectively reverse cell defects. Patients are treated with relevant refined components extracted from healthy cells, thereby enabling diseased organs to again function properly.

Cytoplasmatic Therapy employs an internationally patented method for processing organ components endowed with immunological flexibility, thus making such treatment absolutely safe. The process was developed by Dr. Theurer, who recognised that the therapeutic efficacy of organ preparations must be linked to their molecular components: proteins, lipids, polysaccarides, nucleic acids, and mediators of cellular energy. He perfected a chemical preparation of organ substances by acid-vapour lysis of lyophylised organ powder in a vacuum. The key to his patented method was the removal and reduction of type specificity while maintaining organ specificity and improving the solubility of cell components.

The emergence of Cytoplasmatic Therapy provided a major stimulus to scientific research in organ immunology and offered the medical community effective treatments for myriad ailments--including many diseases once thought incurable--as well as serum desensitisation techniques and even rejuvenation therapy.

Organ therapy with Cytoplasmatic preparations makes use of natural regulatory and metabolic substances with phylogenetic similarity to body components. Impaired regulatory processes are normalized by physiological means, providing causative support for the recovery process. The body of supporting experimental literature from leading universities, institutes and clinics the world over is vast, and there are countless reports of success in human and veterinary practice.

It is precisely the causative effect which draws Cytoplasmatic Therapy so close to the philosophy of the naturopath--both disciplines seek not merely to alleviate the symptoms but to treat the entire body as a whole, as a single entity. So rather than using cells from just one organ, this therapy employs factors from all relevant organs. Monotherapy--using one factor alone--cannot do justice to the principle of holistic medicine because pathophysiological processes are interwoven with the complexity of cybernetic principles. Using macromolecular organ extracts from healthy tissue for holistic therapy in accordance with immunological and allergological principles means treating the cause.

How are preparations obtained?

Cytoplasmatic preparations are extracted from the organs of healthy domestic animals hygienically cultivated for such purposes. The preparations are then frozen at the temperature of liquid nitrogen (-196°C) and finely ground into a powder which is lyophilised. The lyophilised organ powder then is hydrolysed in an acid-vapour vacuum at room temperature (Acid-vapour lysis in a vacumm is the least destructive method of obtaining cell components). Most of the macromolecular organ substances released during this process are water-soluble, allowing for flexible doses. The patented preparation process reduces the type specificity but leaves the organ specificity intact. The process sterilises the preparation, even destroying viruses. Exhaustive sterility checks ensure that the dry powder preparations are safe for use.

The Dry Substances
The preparation method described above produces a fine organ powder. The dry substances are put into ampoules in 15-mg amounts; prior to injection it must be suspended in 2 ml of the vehicle provided.

The Dilutions
The dilutions are prepared from the dry substances. They are aqueous dilution ready for injection and are standardised to human cell cultures according to protein content.

The Lingual Preparations
The lingual preparations are made from dry substances and contain macromoleccular organ mixtures in a concentration of 10-9 g/ml.

Copyright © BioMaxx Holding 2015, All right reserved.